Ultragenyx Pharmaceutical Inc. (RARE)

Ultragenyx Pharmaceutical Revenue

Ultragenyx Pharmaceutical had revenue of $139.49M in the quarter ending September 30, 2024, with 42.27% growth. This brings the company's revenue in the last twelve months to $522.75M, up 27.44% year-over-year. In the year 2023, Ultragenyx Pharmaceutical had annual revenue of $434.25M with 19.52% growth.

• Revenue (ttm): $522.75M
• Revenue Growth: +27.44%
• P/S Ratio: 7.35
• Revenue / Employee: $409,675
• Employees: 1,276
• Market Cap: 4.08B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	434.25M	70.92M	19.52%
Dec 31, 2022	363.33M	11.92M	3.39%
Dec 31, 2021	351.41M	80.38M	29.66%
Dec 31, 2020	271.03M	167.32M	161.32%
Dec 31, 2019	103.71M	52.22M	101.41%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.